Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Takes $10M in Stimulus Orders

NEW YORK (GenomeWeb News) – Bruker said this week that it has taken in $10 million in orders due to stimulus programs in the US, Japan, and Europe.

The firm disclosed in a filing with the US Securities and Exchange Commission that by the end of August it had booked $10 million in orders due the various stimulus programs, with more than $3 million coming from Japan. It said that it had booked five system orders from that country.

In addition, Bruker said that it expected "significant" NMR, MRI, EPR, X-ray crystallography, high-end mass spectrometry, and other system orders during the third and fourth quarters of this year, and into 2010, due to the global stimulus programs.

Bruker also disclosed this information during a presentation this week at a Morgan Stanley institutional investors' conference in Zurich, Switzerland.

"We are encouraged by these orders and believe they will be a key driver f possible upside surprise in BRKR revenues," Leerink Swann analyst Isaac Ro wrote in a research note published today.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.